China review links human and canine leptospirosis evidence

Version 2

A newly published systematic review and meta-analysis in Preventive Veterinary Medicine brings together the epidemiology of human and canine leptospirosis in China, underscoring how the disease continues to sit at the intersection of companion animal medicine and public health. According to the article record, the authors searched six international and Chinese databases for eligible studies published through November 11, 2025, and framed the work as a synthesis to support surveillance and One Health prevention planning. (eurekamag.com)

That framing matters because leptospirosis has a long history in China. A recent review of national human epidemiology noted that the disease was first reported in China in 1937 and was classified as a notifiable infectious disease in 1955. While human incidence has fallen substantially from historical highs, the disease hasn't disappeared, and more recent national analyses suggest it has shown only limited further reduction in recent years, with a slight rebound in reported incidence by 2023. (pmc.ncbi.nlm.nih.gov)

The new paper's contribution is to combine the human and canine evidence base rather than treating them separately. Based on the abstract and indexing information available online, the authors set out to estimate prevalence patterns and examine associated factors for pathogenic Leptospira infection across both populations in China. That kind of paired analysis is especially relevant for a pathogen spread through shared environmental exposure, including contaminated water and urine from reservoir hosts. (eurekamag.com)

Broader recent Chinese research helps explain why this matters for veterinary practice. A 2025 study of dogs in the Yangtze River region described dogs as increasingly valuable sentinels for zoonotic pathogens and argued that urbanized environments still present meaningful leptospirosis risk. The same study said commercially available canine leptospirosis vaccines are widely used in China, while also noting that vaccination can complicate interpretation of serologic findings for some serogroups. (pmc.ncbi.nlm.nih.gov)

Industry or expert reaction specific to this new review wasn't readily available in public-facing commentary at the time of writing. Still, the direction of travel in the literature is consistent. Recent zoonoses analyses from China have called for integrated surveillance systems that combine human reporting, animal surveillance, and environmental exposure data, explicitly citing leptospirosis as a disease that still warrants stronger cross-sector coordination. (idpjournal.biomedcentral.com)

Why it matters: For veterinarians, this is a reminder that leptospirosis surveillance can't stop at individual case management. Reviews like this can help identify where canine infection is being detected, which host or environmental factors recur across studies, and where companion animal data may provide early warning for human risk. In practice, that supports better conversations with pet parents about exposure risk, diagnostics, vaccine decisions, and the importance of considering leptospirosis in dogs with compatible renal, hepatic, or febrile presentations, especially in wet or flood-prone settings. The One Health angle is particularly important as climate and rainfall patterns shift. (pmc.ncbi.nlm.nih.gov)

There are also limits worth noting. Publicly accessible records for the paper provide the study design and rationale, but not the full pooled estimates or subgroup findings, so the most actionable numbers may remain behind the journal paywall for now. That means the headline takeaway is conceptual rather than numeric: this is a synthesis pointing to continued shared risk between people and dogs, not a single surveillance alert. (eurekamag.com)

What to watch: The next step is whether Chinese researchers, regulators, or veterinary networks use findings like these to refine regional surveillance, update canine risk communication, or prioritize dogs more explicitly as sentinel animals in One Health leptospirosis monitoring. (pmc.ncbi.nlm.nih.gov)